UDP-glucuronosyltransferase 1 gene promoter polymorphism is associated with increased serum bilirubin levels and cholecystectomy in patients with sickle cell anemia.

Suppr

超能文献

作者信息

Fertrin K Y, Melo M B, Assis A M, Saad S T O, Costa F F

出版信息

Clin Genet. 2003 Aug;64(2):160-2. doi: 10.1034/j.1399-0004.2003.00113.x.

DOI:10.1034/j.1399-0004.2003.00113.x

PMID:12859413

Abstract

摘要

相似文献

UDP-glucuronosyltransferase 1 gene promoter polymorphism is associated with increased serum bilirubin levels and cholecystectomy in patients with sickle cell anemia.

Clin Genet. 2003 Aug;64(2):160-2. doi: 10.1034/j.1399-0004.2003.00113.x.

Influence of bilirubin uridine diphosphate-glucuronosyltransferase 1A promoter polymorphisms on serum bilirubin levels and cholelithiasis in children with sickle cell anemia.胆红素尿苷二磷酸葡萄糖醛酸基转移酶1A启动子多态性对镰状细胞贫血患儿血清胆红素水平及胆石症的影响

J Pediatr Hematol Oncol. 2001 Oct;23(7):448-51. doi: 10.1097/00043426-200110000-00011.

Early modification of sickle cell disease clinical course by UDP-glucuronosyltransferase 1A1 gene promoter polymorphism.UDP-葡萄糖醛酸基转移酶1A1基因启动子多态性对镰状细胞病临床病程的早期影响

J Hum Genet. 2008;53(6):524-528. doi: 10.1007/s10038-008-0281-3. Epub 2008 Apr 5.

UGT1A promoter polymorphisms influence bilirubin response to hydroxyurea therapy in sickle cell anemia.UGT1A启动子多态性影响镰状细胞贫血患者对羟基脲治疗的胆红素反应。

J Lab Clin Med. 2003 Apr;141(4):279-82. doi: 10.1067/mlc.2003.28.

UGT1A1 polymorphism outweighs the modest effect of deletional (-3.7 kb) alpha-thalassemia on cholelithogenesis in sickle cell anemia.尿苷二磷酸葡萄糖醛酸基转移酶1A1（UGT1A1）基因多态性对镰状细胞性贫血患者胆石症发生的影响，超过了缺失型（-3.7 kb）α地中海贫血的轻微影响。

Am J Hematol. 2006 May;81(5):377-9. doi: 10.1002/ajh.20574.

The linear effects of alpha-thalassaemia, the UGT1A1 and HMOX1 polymorphisms on cholelithiasis in sickle cell disease.α-地中海贫血、UGT1A1和HMOX1基因多态性对镰状细胞病患者胆结石的线性影响。

Br J Haematol. 2007 Jul;138(2):263-70. doi: 10.1111/j.1365-2141.2007.06643.x.

Do Alpha Thalassemia, Fetal Hemoglobin, and the UGT1A1 Polymorphism have an Influence on Serum Bilirubin Levels and Cholelithiasis in Patients with Sickle Cell Disease?α地中海贫血、胎儿血红蛋白和UGT1A1基因多态性对镰状细胞病患者的血清胆红素水平和胆石症有影响吗？

Mol Diagn Ther. 2017 Aug;21(4):437-442. doi: 10.1007/s40291-017-0283-y.

The effect of UGT1A1 promoter polymorphism in the development of hyperbilirubinemia and cholelithiasis in hemoglobinopathy patients.UGT1A1 启动子多态性对血红蛋白病患者高胆红素血症和胆石症发展的影响。

PLoS One. 2013 Oct 30;8(10):e77681. doi: 10.1371/journal.pone.0077681. eCollection 2013.

UGT1A1 promoter polymorphism associated with serum bilirubin level in Saudi patients with sickle cell disease.沙特镰状细胞病患者中与血清胆红素水平相关的UGT1A1启动子多态性

Ann Saudi Med. 2013 Jul-Aug;33(4):372-6. doi: 10.5144/0256-4947.2013.372.

UGT1A1 promoter polymorphisms and the development of hyperbilirubinemia and gallbladder disease in children with sickle cell anemia.UGT1A1启动子多态性与镰状细胞贫血患儿高胆红素血症及胆囊疾病的发生发展

Am J Hematol. 2008 Oct;83(10):800-3. doi: 10.1002/ajh.21264.

引用本文的文献

Genetic Variation and Sickle Cell Disease Severity: A Systematic Review and Meta-Analysis.遗传变异与镰状细胞病严重程度：系统评价和荟萃分析。

JAMA Netw Open. 2023 Oct 2;6(10):e2337484. doi: 10.1001/jamanetworkopen.2023.37484.

Precision Medicine and Sickle Cell Disease.精准医学与镰状细胞病

Hemasphere. 2022 Aug 18;6(9):e762. doi: 10.1097/HS9.0000000000000762. eCollection 2022 Sep.

Influence of UGT1A1 promoter polymorphism, α-thalassemia and β haplotype in bilirubin levels and cholelithiasis in a large sickle cell anemia cohort.UGT1A1 启动子多态性、α-地中海贫血和β 单倍型对大型镰状细胞贫血队列中胆红素水平和胆石症的影响。

Ann Hematol. 2021 Apr;100(4):903-911. doi: 10.1007/s00277-021-04422-1. Epub 2021 Feb 1.

Uridine diphosphate glucuronosyl transferase 1A (UGT1A1) promoter polymorphism in young patients with sickle cell anaemia: report of the first cohort study from Nigeria.年轻镰状细胞贫血症患者的尿苷二磷酸葡萄糖醛酸基转移酶 1A（UGT1A1）启动子多态性：来自尼日利亚的首个队列研究报告。

BMC Med Genet. 2019 Oct 16;20(1):160. doi: 10.1186/s12881-019-0899-3.

Sickle Cell Anemia and Its Phenotypes.镰状细胞贫血及其表型。

Annu Rev Genomics Hum Genet. 2018 Aug 31;19:113-147. doi: 10.1146/annurev-genom-083117-021320. Epub 2018 Apr 11.

Mol Diagn Ther. 2017 Aug;21(4):437-442. doi: 10.1007/s40291-017-0283-y.

Minireview: Clinical severity in sickle cell disease: the challenges of definition and prognostication.综述：镰状细胞病的临床严重程度：定义与预后的挑战

Exp Biol Med (Maywood). 2016 Apr;241(7):679-88. doi: 10.1177/1535370216640385. Epub 2016 Mar 23.

Minireview: Genetic basis of heterogeneity and severity in sickle cell disease.小型综述：镰状细胞病异质性和严重程度的遗传基础

Exp Biol Med (Maywood). 2016 Apr;241(7):689-96. doi: 10.1177/1535370216636726. Epub 2016 Mar 1.

Genomic approaches to identifying targets for treating β hemoglobinopathies.用于鉴定β-血红蛋白病治疗靶点的基因组学方法。

BMC Med Genomics. 2015 Jul 29;8:44. doi: 10.1186/s12920-015-0120-2.

Early complication in sickle cell anemia children due to A(TA)nTAA polymorphism at the promoter of UGT1A1 gene.由于 UGT1A1 基因启动子处的 A(TA)nTAA 多态性，镰状细胞贫血儿童的早期并发症。

Dis Markers. 2013;35(2):67-72. doi: 10.1155/2013/173474. Epub 2013 Jul 28.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验